Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Boots Migraine Pain Relief Ibuprofen lysine 342mg tablets
1001010ADBGABAB
|
Boots (Ibuprofen lysine) | Ibuprofen lysine | Musculoskeletal and Joint Diseases | No data available |
|
Boots Pain Relief balm
1003020T0BRAAAG
|
Boots Pain Relief balm | Nicotinates | Musculoskeletal and Joint Diseases | No data available |
|
Boots Period Pain Reliever 250mg gastro-resistant tablets
1001010P0BWAAAH
|
Boots (Naproxen) | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Boots Rapid Ibuprofen lysine 342mg tablets
1001010ADBGAAAB
|
Boots (Ibuprofen lysine) | Ibuprofen lysine | Musculoskeletal and Joint Diseases | No data available |
|
Boots Warming Pain Relief spray
1003020N0BRAAA0
|
Boots Warming Pain Relief | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Brexidol 20mg tablets
1001010R0BHAAAK
|
Brexidol | Piroxicam | Musculoskeletal and Joint Diseases | No data available |
|
Brufen 200mg tablets
1001010J0BCAAAD
|
Brufen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Butacote 100mg gastro-resistant tablets
1001010Q0BBAAAB
|
Butacote | Phenylbutazone | Musculoskeletal and Joint Diseases | No data available |
|
Calprofen 100mg/5ml oral suspension 5ml sachets
1001010J0DBACBM
|
Calprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Calprofen 100mg/5ml oral suspension paediatric
1001010J0DBABBH
|
Calprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Caplenal 100mg tablets
1001040C0BDAAAA
|
Caplenal | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Caplenal 300mg tablets
1001040C0BDABAB
|
Caplenal | Allopurinol | Musculoskeletal and Joint Diseases | No data available |
|
Capsaicin 0.006% cream
1003020AAAAACAC
|
Capsaicin | Capsaicin | Musculoskeletal and Joint Diseases | No data available |
|
Capsicum 2.466% ointment
1003020H0AAAHAH
|
Capsicum | Capsicum | Musculoskeletal and Joint Diseases | No data available |
|
Captimer 250mg tablets
1001030Q0BCAAAB
|
Captimer | Tiopronin | Musculoskeletal and Joint Diseases | No data available |
|
Care Ibuprofen for Children 100mg/5ml oral suspension
1001010J0CUABBH
|
Care Ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Care Pain Relief 2.32% gel
1003020AFBDAAAB
|
Care Pain Relief | Diclofenac diethyl | Musculoskeletal and Joint Diseases | No data available |
|
Carisoma 125mg tablets
1002020G0BBAAAA
|
Carisoma | Carisoprodol | Musculoskeletal and Joint Diseases | No data available |
|
Carisoma 350mg tablets
1002020G0BBABAB
|
Carisoma | Carisoprodol | Musculoskeletal and Joint Diseases | No data available |
|
Carisoprodol 125mg tablets
1002020G0AAAAAA
|
Carisoprodol | Carisoprodol | Musculoskeletal and Joint Diseases | No data available |
|
Carisoprodol 350mg tablets
1002020G0AAABAB
|
Carisoprodol | Carisoprodol | Musculoskeletal and Joint Diseases | No data available |
|
Celecoxib 400mg capsules
1001010AHAAADAD
|
Celecoxib | Celecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Celecoxib 50mg/5ml oral suspension
1001010AHAAAEAE
|
Celecoxib | Celecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Certolizumab pegol 200mg/1ml inj cartridges
1001030Y0AAACAC
|
Certolizumab pegol | Certolizumab pegol | Musculoskeletal and Joint Diseases | No data available |
|
Certolizumab pegol 200mg/1ml inj pf disposable devices
1001030Y0AAABAB
|
Certolizumab pegol | Certolizumab pegol | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.